Literature DB >> 18792844

Reference values for alpha1-acid glycoprotein, alpha1-antitrypsin, albumin, haptoglobin, C-reactive protein, IgA, IgG and IgM during pregnancy.

Anders Larsson1, Maria Palm, Lars-Olof Hansson, Samar Basu, Ove Axelsson.   

Abstract

The objective of this study was to establish reference intervals and decision limits for the interpretation of the acute phase proteins alpha(1)-acid glycoprotein (orosomucoid), alpha(1)-antitrypsin, C-reactive protein (CRP), haptoglobin and albumin, IgA, IgG and IgM during pregnancy by longitudinal sampling from 52 healthy women with normal pregnancies. Each woman was sampled in weeks 7-17; weeks 17-24; weeks 24-28; weeks 28-31; weeks 31-34; weeks 34-38 and predelivery (-14-0 days prior to delivery) and postpartum (>6 weeks after delivery). The 2.5th and 97.5th percentiles were calculated according to the recommendations of the International Federation of Clinical Chemistry on the statistical treatment of reference values. Reference values for alpha(1)-acid glycoprotein, alpha(1)-antitrypsin, albumin, haptoglobin, CRP, IgA, IgG and IgM are reported. Most of these proteins changed during normal pregnancy, as a reflection of the major physiological and biochemical changes that occur in pregnancy. A laboratory test result from a pregnant woman should be compared with pregnancy-specific reference intervals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18792844     DOI: 10.1080/00016340802428146

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  23 in total

1.  Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women.

Authors:  Rodrigo Metzker Pereira Ribeiro; Fernanda de Lima Moreira; Elaine Christine Dantas Moisés; Ricardo Carvalho Cavalli; Silvana Maria Quintana; Vera Lucia Lanchote; Geraldo Duarte
Journal:  Br J Clin Pharmacol       Date:  2018-08-02       Impact factor: 4.335

Review 2.  Periodontitis, cardiovascular disease and pregnancy outcome--focal infection revisited?

Authors:  M Ide; G J Linden
Journal:  Br Dent J       Date:  2014-10       Impact factor: 1.626

Review 3.  Expanding the clinical indications for α(1)-antitrypsin therapy.

Authors:  Eli C Lewis
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

4.  Impact of Disease Activity and Inflammatory Bowel Disease Subtype on Quality of Life in Preconception and Pregnant Patients.

Authors:  Grace Wang; Parul Tandon; Nicole Rodriguez; Lindsy Ambrosio; Reed T Sutton; Levinus A Dieleman; Karen I Kroeker; Vivian Huang
Journal:  Dig Dis Sci       Date:  2022-08-05       Impact factor: 3.487

5.  Serum inflammatory mediators in pregnancy: changes after periodontal treatment and association with pregnancy outcomes.

Authors:  Bryan S Michalowicz; M John Novak; James S Hodges; Anthony DiAngelis; William Buchanan; Panos N Papapanou; Dennis A Mitchell; James E Ferguson; Virginia Lupo; James Bofill; Stephen Matseoane; Michelle Steffen; Jeffrey L Ebersole
Journal:  J Periodontol       Date:  2009-11       Impact factor: 6.993

6.  Monocyte CD49e and 110-120 kDa fibronectin fragments: HIV prognostic indicators independent of viral load and CD4 T-cell counts.

Authors:  Roger D Rossen; Jose A Rubio; Wendy J Porter; JoAnn Trial; Frank M Orson; Maria C Rodriguez-Barradas; Holly H Birdsall
Journal:  AIDS       Date:  2009-11-13       Impact factor: 4.177

7.  Longitudinal changes in serum proinflammatory markers across pregnancy and postpartum: effects of maternal body mass index.

Authors:  Lisa M Christian; Kyle Porter
Journal:  Cytokine       Date:  2014-07-28       Impact factor: 3.861

8.  High-throughput Serum N-Glycomics: Method Comparison and Application to Study Rheumatoid Arthritis and Pregnancy-associated Changes.

Authors:  Karli R Reiding; Albert Bondt; René Hennig; Richard A Gardner; Roisin O'Flaherty; Irena Trbojević-Akmačić; Archana Shubhakar; Johanna M W Hazes; Udo Reichl; Daryl L Fernandes; Maja Pučić-Baković; Erdmann Rapp; Daniel I R Spencer; Radboud J E M Dolhain; Pauline M Rudd; Gordan Lauc; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2018-09-21       Impact factor: 5.911

9.  A study of the effects of latent iron deficiency on measures of cognition: a pilot randomised controlled trial of iron supplementation in young women.

Authors:  Alecia J Leonard; Kerry A Chalmers; Clare E Collins; Amanda J Patterson
Journal:  Nutrients       Date:  2014-06-23       Impact factor: 5.717

10.  Comparison of two doses of elemental iron in the treatment of latent iron deficiency: efficacy, side effects and blinding capabilities.

Authors:  Alecia J Leonard; Kerry A Chalmers; Clare E Collins; Amanda J Patterson
Journal:  Nutrients       Date:  2014-04-04       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.